Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in QURE — uniQure N.V.

CIK 1387508 NEW YORK, NY

Position in QURE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,484,467
+$1,107,833 QoQ
Shares Held
32,229
+104.8% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#116
of 252 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in QURE Over Time

Shares Held

Position Value (USD)

Derivatives in QURE

reported options exposure · as of Jun 30, 2020
CallValue
$9,012
CallShares
200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names. QURE ranks #6 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 QURE
uniQure N.V.
This page
32,229 $1,484,467

All Filings in QURE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,484,467 32,229
2025-12-31 $376,634 15,739
2025-09-30 $709,779 12,160
2023-09-30 $84,103 12,534
2023-06-30 $137,623 12,009
2021-03-31 $202,140 6,000
2020-12-31 $216,780 6,000
2020-09-30 $99,441 2,700
2020-06-30 $121,662 2,700
2020-06-30 $9,012 200